Dr. Scurlock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Arkansas Children's Hospital
1 Children's Way
Little Rock, AR 72202Phone+1 501-263-2621
Education & Training
- Duke University HospitalFellowship, Allergy and Immunology, 2002 - 2004
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1998 - 2002
- University of Arkansas For Medical Sciences College of MedicineClass of 1998
Certifications & Licensure
- AR State Medical License 2001 - 2026
- NC State Medical License 2002 - 2006
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Clinical Trials
- Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract Start of enrollment: 2006 Feb 01
- Immunopathogenesis of Chlamydia Start of enrollment: 2008 Jan 01
- Allergic Disease Onset Prevention Study Start of enrollment: 2021 Sep 01
Roles: Contact
Publications & Presentations
PubMed
- Food Insecurity and Health Inequities in Food Allergy.Akilah A Jefferson, Lauren Davidson, Amy M Scurlock, Jessica Stern
Current Allergy and Asthma Reports. 2024-04-01 - 42 citationsOmalizumab for the Treatment of Multiple Food Allergies.Robert A Wood, Alkis Togias, Scott H Sicherer, Wayne G Shreffler, Edwin H Kim
The New England Journal of Medicine. 2024-03-07 - 6 citationsThe SunBEAm birth cohort: Protocol design.Corinne Keet, Scott H Sicherer, Supinda Bunyavanich, Cynthia Visness, Patricia C Fulkerson
The Journal of Allergy and Clinical Immunology. Global. 2023-08-01
Press Mentions
- NIH Clinical Trial Conducted in Part at Arkansas Children’s Produces First FDA-Approved Treatment for Multiple Severe Food AllergiesFebruary 29th, 2024
- DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019June 1st, 2019
- Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food AllergiesFebruary 26th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Society for Pediatric Research (SPR)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: